Genetic testing by cancer site

Pancreas

Jennifer E. Axilbund, Elizabeth A. Wiley

Research output: Contribution to journalArticle

Abstract

It is estimated that 5% to 10% of pancreatic cancer is familial. Although there is evidence of a major pancreatic cancer susceptibility gene, the majority of families with multiple cases of pancreatic cancer do not have an identifiable causative gene or syndrome. However, a subset of pancreatic cancer is attributable to known inherited cancer predisposition syndromes, including several hereditary breast cancer genes (BRCA1, BRCA2, and PALB2), CDKN2A, hereditary pancreatitis, hereditary nonpolyposis colorectal cancer, and Peutz-Jeghers syndrome. In addition to explaining a proportion of familial pancreatic cancer, individuals with these conditions are at increased risk for pancreatic cancer. Relatives from familial pancreatic cancer kindreds without one of these identifiable syndromes may have as high as a 32-fold risk of pancreatic cancer, depending on the number of affected first-degree relatives. Such high-risk individuals may benefit from increased surveillance, and strategies for early detection of pancreatic cancer are under evaluation.

Original languageEnglish (US)
Pages (from-to)350-354
Number of pages5
JournalCancer Journal (United States)
Volume18
Issue number4
DOIs
StatePublished - Jul 2012

Fingerprint

Genetic Testing
Pancreatic Neoplasms
Neoplasm Genes
Peutz-Jeghers Syndrome
Hereditary Nonpolyposis Colorectal Neoplasms
Early Detection of Cancer
Breast Neoplasms

Keywords

  • familial cancer
  • genetics
  • hereditary syndrome
  • Pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic testing by cancer site : Pancreas. / Axilbund, Jennifer E.; Wiley, Elizabeth A.

In: Cancer Journal (United States), Vol. 18, No. 4, 07.2012, p. 350-354.

Research output: Contribution to journalArticle

Axilbund, Jennifer E. ; Wiley, Elizabeth A. / Genetic testing by cancer site : Pancreas. In: Cancer Journal (United States). 2012 ; Vol. 18, No. 4. pp. 350-354.
@article{5347b53095c54ccd892661c631bfc85a,
title = "Genetic testing by cancer site: Pancreas",
abstract = "It is estimated that 5{\%} to 10{\%} of pancreatic cancer is familial. Although there is evidence of a major pancreatic cancer susceptibility gene, the majority of families with multiple cases of pancreatic cancer do not have an identifiable causative gene or syndrome. However, a subset of pancreatic cancer is attributable to known inherited cancer predisposition syndromes, including several hereditary breast cancer genes (BRCA1, BRCA2, and PALB2), CDKN2A, hereditary pancreatitis, hereditary nonpolyposis colorectal cancer, and Peutz-Jeghers syndrome. In addition to explaining a proportion of familial pancreatic cancer, individuals with these conditions are at increased risk for pancreatic cancer. Relatives from familial pancreatic cancer kindreds without one of these identifiable syndromes may have as high as a 32-fold risk of pancreatic cancer, depending on the number of affected first-degree relatives. Such high-risk individuals may benefit from increased surveillance, and strategies for early detection of pancreatic cancer are under evaluation.",
keywords = "familial cancer, genetics, hereditary syndrome, Pancreatic cancer",
author = "Axilbund, {Jennifer E.} and Wiley, {Elizabeth A.}",
year = "2012",
month = "7",
doi = "10.1097/PPO.0b013e3182624694",
language = "English (US)",
volume = "18",
pages = "350--354",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "0765-7846",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "4",

}

TY - JOUR

T1 - Genetic testing by cancer site

T2 - Pancreas

AU - Axilbund, Jennifer E.

AU - Wiley, Elizabeth A.

PY - 2012/7

Y1 - 2012/7

N2 - It is estimated that 5% to 10% of pancreatic cancer is familial. Although there is evidence of a major pancreatic cancer susceptibility gene, the majority of families with multiple cases of pancreatic cancer do not have an identifiable causative gene or syndrome. However, a subset of pancreatic cancer is attributable to known inherited cancer predisposition syndromes, including several hereditary breast cancer genes (BRCA1, BRCA2, and PALB2), CDKN2A, hereditary pancreatitis, hereditary nonpolyposis colorectal cancer, and Peutz-Jeghers syndrome. In addition to explaining a proportion of familial pancreatic cancer, individuals with these conditions are at increased risk for pancreatic cancer. Relatives from familial pancreatic cancer kindreds without one of these identifiable syndromes may have as high as a 32-fold risk of pancreatic cancer, depending on the number of affected first-degree relatives. Such high-risk individuals may benefit from increased surveillance, and strategies for early detection of pancreatic cancer are under evaluation.

AB - It is estimated that 5% to 10% of pancreatic cancer is familial. Although there is evidence of a major pancreatic cancer susceptibility gene, the majority of families with multiple cases of pancreatic cancer do not have an identifiable causative gene or syndrome. However, a subset of pancreatic cancer is attributable to known inherited cancer predisposition syndromes, including several hereditary breast cancer genes (BRCA1, BRCA2, and PALB2), CDKN2A, hereditary pancreatitis, hereditary nonpolyposis colorectal cancer, and Peutz-Jeghers syndrome. In addition to explaining a proportion of familial pancreatic cancer, individuals with these conditions are at increased risk for pancreatic cancer. Relatives from familial pancreatic cancer kindreds without one of these identifiable syndromes may have as high as a 32-fold risk of pancreatic cancer, depending on the number of affected first-degree relatives. Such high-risk individuals may benefit from increased surveillance, and strategies for early detection of pancreatic cancer are under evaluation.

KW - familial cancer

KW - genetics

KW - hereditary syndrome

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84864622853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864622853&partnerID=8YFLogxK

U2 - 10.1097/PPO.0b013e3182624694

DO - 10.1097/PPO.0b013e3182624694

M3 - Article

VL - 18

SP - 350

EP - 354

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 0765-7846

IS - 4

ER -